Ocrelizumab treatment in patients with progressive multiple sclerosis: a single-center real-world experience

被引：0
|
作者：
Cellerino, Maria [1 ]
Boffa, Giacomo [1 ]
Lapucci, Caterina [2 ]
Sbragia, Elvira [1 ]
Bruschi, Nicolo [1 ]
Mancuso, Elisabetta [1 ]
Tazza, Francesco [1 ]
Poire, Ilaria [3 ]
Laroni, Alice [3 ]
Capello, Elisabetta [3 ]
Uccelli, Antonio [1 ,3 ]
Novi, Giovanni [3 ]
Inglese, Matilde [1 ]
机构：
[1] Univ Genoa, DINOGMI, Genoa, Italy
[2] Lab Neurosci Sperimentali, Osped Policlin San Martino IRCCS, Genoa, Italy
[3] Dept Neurol, Osped Policlin San Martino IRCCS, Genoa, Italy
来源：
NEUROLOGY | 2021年 / 96卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
2504
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Hypogammaglobulinemia and infection rates in ocrelizumab treated multiple sclerosis patients over 3 years: a real-world single center study
    Khatri, B.
    Van Zealand, P.
    Tarima, S.
    Schutten, S.
    Baker, A.
    Sershon, L.
    Fenton, K.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 626 - 626
  • [32] Effectiveness of rituximab vs. ocrelizumab for the treatment of primary progressive multiple sclerosis: a real-world observational study
    Alcala, Carmen
    Quintanilla-Bordas, Carlos
    Gascon, Francisco
    Sempere, Angel Perez
    Navarro, Laura
    Carcelen-Gadea, Maria
    Landete, Lamberto
    Mallada, Javier
    Canizares, Emmanuel
    Belenguer, Antonio
    Carratala, Sara
    Dominguez, Jose Andres
    Perez-Miralles, Francisco Carlos
    Gil-Perotin, Sara
    Gasque, Raquel
    Cubas, Laura
    Castillo, Jessica
    Casanova, Bonaventura
    JOURNAL OF NEUROLOGY, 2022, 269 (07) : 3676 - 3681
  • [33] Treatment patterns of patients with multiple sclerosis in China: A single-center experience
    Li, Rui
    Wang, Jingqi
    Li, Jing
    Wang, Yuge
    Wu, Haotian
    Fan, Ping
    Zhong, Xiaonan
    Lau, Alexander Y.
    Kermode, Allan G.
    Qiu, Wei
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (09) : NP45 - NP46
  • [34] Ocrelizumab real-world safety and effectiveness in the two years of treatment in multiple sclerosis
    Vollmer, B.
    Declusin, A.
    Nair, K.
    Sillau, S.
    Corboy, J.
    Vollmer, T.
    Alvarez, E.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 294 - 295
  • [35] Real-world evidence on siponimod treatment in patients with secondary progressive multiple sclerosis
    Regner-Nelke, Liesa
    Pawlitzki, Marc
    Willison, Alice
    Rolfes, Leoni
    Oezalp, Sinem-Hilal
    Nelke, Christopher
    Koelsche, Tristan
    Korsen, Melanie
    Grothe, Matthias
    Groppa, Sergiu
    Luessi, Felix
    Engel, Sinah
    Nelles, Gereon
    Bonmann, Eckhard
    Roick, Holger
    Friedrich, Anke
    Knorn, Philipp
    Landefeld, Harald
    Biro, Zoltan
    Ernst, Michael
    Bayas, Antonios
    Menacher, Martina
    Akgun, Katja
    Kleinschnitz, Christoph
    Ruck, Tobias
    Ziemssen, Tjalf
    Pul, Refik
    Meuth, Sven G.
    NEUROLOGICAL RESEARCH AND PRACTICE, 2022, 4 (01):
  • [36] Real-World Experience with Ocrelizumab
    Moss, Brandon
    Utigard, Erica
    Baldassari, Laura
    Cohen, Jeffrey
    Ontaneda, Daniel
    NEUROLOGY, 2018, 90
  • [37] Real-World Experience with Ocrelizumab
    Moss, Brandon P.
    Utigard, Erica
    Baldassari, Laura E.
    Cohen, Jeffrey A.
    Ontaneda, Daniel D.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 69 - 70
  • [38] Real-world experience with ocrelizumab
    Moss, B.
    Parrotta, E.
    Baldassari, L.
    Planchon, S.
    Cohen, J.
    Ontaneda, D.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 780 - 781
  • [39] Ocrelizumab real-world experience
    Moss, B.
    Utigard, E.
    Baldassari, L.
    Cohen, J.
    Ontaneda, D.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 504 - 505
  • [40] Mitoxantrone in the Treatment of Multiple Sclerosis: a Single-Center Experience
    Taskapilioglu, Ozlem
    Sener, Deniz Kamaci
    Turan, Asli Bahar
    Yurtogullari, Sukran
    Tutuncu, Ahmet
    Gullulu, Sumeyye
    Ocakoglu, Gokhan
    Turan, Omer Faruk
    TURKISH JOURNAL OF NEUROLOGY, 2012, 18 (02) : 62 - 66
12345